3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Motor Activity
22
Breast Neoplasms
14
Neoplasms
9
Fatigue
5
Prostatic Neoplasms
4
Obesity
4
Pancreatic Neoplasms
3
Colorectal Neoplasms
3
Peripheral Nervous System Diseases
2
Overweight
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lung Neoplasms
2
Cognitive Dysfunction
2
Cardiovascular Diseases
2
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Smoking
1
Skin Neoplasms
1
Recurrence
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Ovarian Neoplasms
1
Osteolysis
1
Non-alcoholic Fatty Liver Disease
1
Neuroectodermal Tumors, Primitive
1
Neurocognitive Disorders
1
Multiple Endocrine Neoplasia Type 1
1
Metabolic Syndrome
1
Interventions
semaglutide
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Walking
1
Topiramate
1
Tirzepatide
1
Qsymia
1
Phentermine
1
Naltrexone
1
Liraglutide
1
Glucagon-Like Peptide-1 Receptor
1
Exercise
1
Diethylpropion
1
Bupropion
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Metabolic Syndrome
×
Exercise
×
Clear all
NCT07157371
2025-09-05
SSAET
Riphah International University
Phase NA
Active not recruiting
60 enrolled